Paolo Farneti/LinkedIn
Aug 11, 2025, 01:43
Delphi Consensus: A Safe Guide to Use of Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-related Epistaxis
JAMA Otolaryngology – Head & Neck Surgery shared an insightful post on X:
”A Delphi consensus among six international experts established 30 statements to guide the safe and effective use of sclerotherapy for hereditary hemorrhagic telangiectasia (HHT)-related epistaxis.”
Read the full article here.
Article: Consensus on Sclerotherapy for Patients With Hereditary Hemorrhagic Telangiectasia–Related Epistaxis
Authors: Paolo Farneti, Sol Marcos-Salazar, Claudia Crocione,Holly Boyer, Roberto Puxeddu, Alan B. Whitehouse, Jay F. Piccirillo
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia